Liangfeng Wei
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Liangfeng Wei has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Shousen Wang
Department of Neurosurgery, Fuzong Clinical Medical College of Fujian Medical University, Fuzhou, China
6 shared publications Pengwei Hou
Department of Neurosurgery, Jinjiang Municipal Hospital (Shanghai Sixth People's Hospital), Jinjiang
4 shared publicationsYehuang Chen
Department of Neurosurgery, 900th Hospital, Fujian Provincial Clinical Medical Research Center for Minimally Invasive Diagnosis and Treatment of Neurovascular Diseases, Fuzhou, China
3 shared publicationsDan Ye
Department of Neurosurgery, Fuzong Clinical Medical College of Fujian Medical University, Fuzhou, CHN
2 shared publicationsJun Li
Department of Neurosurgery, Fuzong Clinical Medical College of Fujian Medical University
2 shared publicationsQizuan Chen
Fuzong Clinical Medical College of Fujian Medical University, Fuzhou, China
2 shared publications
Latest Publications
- Open Access
- 11 August 2026
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 17, 1843121
Predicting 3-month prognosis of cerebral venous thrombosis: a machine learning approach incorporating inflammatory markers
This study aimed to explore a machine learning (ML) model for predicting the long-term prognosis of Cerebral Venous Thrombosis (CVT). We conducted a comprehensive retrospective analysis on CVT patients admitted to Fujian Medical University Fuzhou General Hospital and The Affiliated Zhongshan Hospital of Xiamen University from January 1, 2020 to December 31, 2023. The retrospective cohort of 350 patients was used for model development using a 5-fold nested cross-validation framework. To address class imbalance, the Borderline-SMOTE technique was applied within the internal training folds. A total of 31 clinical and laboratory variables were evaluated as potential predictors. Lasso and Elastic Net (cv-Enet) were employed for preliminary variable selection, and the intersection of these two methods yielded 11 key variables. Random Forest was then applied to further reduce dimensionality, resulting in a final set of 5 crucial variables. These variables were ranked by importance using SHapley Additive exPlanation (SHAP) analysis. In internal validation using nested cross-validation, the SVM model achieved an area under the receiver operating characteristic curve (AUROC) of 0.870, with a sensitivity of 0.784 and a specificity of 0.897. This performance was corroborated in an independent, prospectively collected external cohort of 152 patients from the First Hospital of Shanxi Medical University (January 1, 2023 to December 31, 2025) where the model demonstrated robust discrimination with an AUROC of 0.862 (95% CI: 0.829–0.884). However, calibration analysis indicated a slight overestimation of risk (calibration-in-the-large ≈ 9%), suggesting that the model currently serves best as a risk stratification adjunct rather than a definitive outcome predictor. Bootstrap resampling confirmed the stability of the discriminative performance. Exploratory subgroup and fairness analyses suggested stable model performance across key demographic subgroups. Our study focused on the development and validation of an ML-based model for long-term CVT prognosis prediction, highlighting the significant role of inflammatory markers. These findings indicate that the SVM model, with further calibration and prospective validation, could serve as a useful adjunct for risk stratification in CVT.
- 11 August 2026
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 17, 1843121
Open AccessPredicting 3-month prognosis of cerebral venous thrombosis: a machine learning approach incorporating inflammatory markers
This study aimed to explore a machine learning (ML) model for predicting the long-term prognosis of Cerebral Venous Thrombosis (CVT). We conducted a comprehensive retrospective analysis on CVT patients admitted to Fujian Medical University Fuzhou General Hospital and The Affiliated Zhongshan Hospital of Xiamen University from January 1, 2020 to December 31, 2023. The retrospective cohort of 350 patients was used for model development using a 5-fold nested cross-validation framework. To address class imbalance, the Borderline-SMOTE technique was applied within the internal training folds. A total of 31 clinical and laboratory variables were evaluated as potential predictors. Lasso and Elastic Net (cv-Enet) were employed for preliminary variable selection, and the intersection of these two methods yielded 11 key variables. Random Forest was then applied to further reduce dimensionality, resulting in a final set of 5 crucial variables. These variables were ranked by importance using SHapley Additive exPlanation (SHAP) analysis. In internal validation using nested cross-validation, the SVM model achieved an area under the receiver operating characteristic curve (AUROC) of 0.870, with a sensitivity of 0.784 and a specificity of 0.897. This performance was corroborated in an independent, prospectively collected external cohort of 152 patients from the First Hospital of Shanxi Medical University (January 1, 2023 to December 31, 2025) where the model demonstrated robust discrimination with an AUROC of 0.862 (95% CI: 0.829–0.884). However, calibration analysis indicated a slight overestimation of risk (calibration-in-the-large ≈ 9%), suggesting that the model currently serves best as a risk stratification adjunct rather than a definitive outcome predictor. Bootstrap resampling confirmed the stability of the discriminative performance. Exploratory subgroup and fairness analyses suggested stable model performance across key demographic subgroups. Our study focused on the development and validation of an ML-based model for long-term CVT prognosis prediction, highlighting the significant role of inflammatory markers. These findings indicate that the SVM model, with further calibration and prospective validation, could serve as a useful adjunct for risk stratification in CVT.
- Open Access
- 6 April 2026
- Published by Springer Nature in Cureus
- Vol. 18 (4)
Analysis of Microbial Community Structure in the Coastal Waters of Island Cities: Based on High-Throughput Sequencing and Traditional Bacterial Culturing
Background: Coastal water microbial communities are highly diverse and often undergo changes with variations in environmental conditions. This study focuses on the seawater around Pingtan, utilizing Illumina MiSeq sequencing (San Diego, California, United States) and bacterial cultivation techniques to analyze the abundance and relative composition of planktonic bacterial communities.
- 6 April 2026
- Published by Springer Nature in Cureus
- Vol. 18 (4)
Open AccessAnalysis of Microbial Community Structure in the Coastal Waters of Island Cities: Based on High-Throughput Sequencing and Traditional Bacterial Culturing
Background: Coastal water microbial communities are highly diverse and often undergo changes with variations in environmental conditions. This study focuses on the seawater around Pingtan, utilizing Illumina MiSeq sequencing (San Diego, California, United States) and bacterial cultivation techniques to analyze the abundance and relative composition of planktonic bacterial communities.
- 26 January 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (2) , 197
Comprehensive evaluation and analysis of pituitary hormones in male patients with non-functional pituitary adenoma during the perioperative period
Objective To analyze perioperative hormonal changes in male patients with non-functioning pituitary adenomas undergoing transsphenoidal surgery and establish a method for assessing adenopituitary function. Methods We retrospectively analyzed preoperative clinical and imaging data, and perioperative anterior pituitary hormone levels of 123 male non-functioning pituitary adenomas patients who underwent surgery from 2012 to 2022. Hormone scores were calculated using an inverse tangent function normalized to normal hormone levels (0–1). Total pituitary hormone score summed six hormones (GH, ACTH, TSH, PRL, FSH, LH) reflecting overall pituitary secretion. ROC curves and AUC were calculated for assessment. Results Most hormone levels (except GH, FSH) and total scores decreased postoperatively in large/giant adenoma groups, recovering by 3 months. Significant preoperative and postoperative differences were found in GH, TSH, LH, and total scores (P < 0.05). TSH, PRL, FSH, and total scores showed significant time-related changes, while GH, ACTH, and LH remained stable. Total scores differed significantly between patients with and without preoperative hypopituitarism (P < 0.001 for ACTH, FSH, LH, TSH). Prediction models had AUCs of 0.755 and 0.636 for patients without and with preoperative hypopituitarism, respectively. Conclusions Male non-functioning pituitary adenomas patients experienced immediate postoperative hormonal drops, followed by gradual recovery. The total hormone score efficiently assessed pituitary function, simplifying complex hormonal dynamics.
- 26 January 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (2) , 197
Comprehensive evaluation and analysis of pituitary hormones in male patients with non-functional pituitary adenoma during the perioperative period
Objective To analyze perioperative hormonal changes in male patients with non-functioning pituitary adenomas undergoing transsphenoidal surgery and establish a method for assessing adenopituitary function. Methods We retrospectively analyzed preoperative clinical and imaging data, and perioperative anterior pituitary hormone levels of 123 male non-functioning pituitary adenomas patients who underwent surgery from 2012 to 2022. Hormone scores were calculated using an inverse tangent function normalized to normal hormone levels (0–1). Total pituitary hormone score summed six hormones (GH, ACTH, TSH, PRL, FSH, LH) reflecting overall pituitary secretion. ROC curves and AUC were calculated for assessment. Results Most hormone levels (except GH, FSH) and total scores decreased postoperatively in large/giant adenoma groups, recovering by 3 months. Significant preoperative and postoperative differences were found in GH, TSH, LH, and total scores (P < 0.05). TSH, PRL, FSH, and total scores showed significant time-related changes, while GH, ACTH, and LH remained stable. Total scores differed significantly between patients with and without preoperative hypopituitarism (P < 0.001 for ACTH, FSH, LH, TSH). Prediction models had AUCs of 0.755 and 0.636 for patients without and with preoperative hypopituitarism, respectively. Conclusions Male non-functioning pituitary adenomas patients experienced immediate postoperative hormonal drops, followed by gradual recovery. The total hormone score efficiently assessed pituitary function, simplifying complex hormonal dynamics.
- Open Access
- 1 December 2025
- Published by Springer Nature in BMC Endocrine Disorders
- Vol. 26 (1)
Clinical, radiological, and pathological characteristics and long-term outcomes of silent corticotroph adenomas: a retrospective study
Silent corticotroph adenomas (SCAs), a subtype of non-functioning pituitary adenomas (NFPAs), exhibit aggressive biological behaviour despite the absence o
- 1 December 2025
- Published by Springer Nature in BMC Endocrine Disorders
- Vol. 26 (1)
Open AccessClinical, radiological, and pathological characteristics and long-term outcomes of silent corticotroph adenomas: a retrospective study
Silent corticotroph adenomas (SCAs), a subtype of non-functioning pituitary adenomas (NFPAs), exhibit aggressive biological behaviour despite the absence o
- Open Access
- 5 September 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (1) , 2008-2009
Letter to the Editor: Preoperative hemorrhagic risk stratification in pediatric moyamoya disease: a multi-institutional propensity score-matched analysis
- 5 September 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (1) , 2008-2009
Open AccessLetter to the Editor: Preoperative hemorrhagic risk stratification in pediatric moyamoya disease: a multi-institutional propensity score-matched analysis
- Open Access
- 24 June 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-16
Assessment of cerebrovascular alterations induced by inflammatory response and oxidative–nitrative stress after traumatic intracranial hypertension and a potential mitigation strategy
The rapid perfusion of cerebral arteries leads to a significant increase in intracranial blood volume, exposing patients with traumatic brain injury to the risk of diffuse brain swelling or malignant brain herniation during decompressive craniectomy. The microcirculation and venous system are also involved in this process, but the precise mechanisms remain unclear. A physiological model of extremely high intracranial pressure was created in rats. This development triggered the TNF-α/NF-κB/iNOS axis in microglia, and released many inflammatory factors and reactive oxygen species/reactive nitrogen species, generating an excessive amount of peroxynitrite. Subsequently, the capillary wall cells especially pericytes exhibited severe degeneration and injury, the blood–brain barrier was disrupted, and a large number of blood cells were deposited within the microcirculation, resulting in a significant delay in the recovery of the microcirculation and venous blood flow compared to arterial flow, and this still persisted after decompressive craniectomy. Infliximab is a monoclonal antibody bound to TNF-α that effectively reduces the activity of TNF-α/NF-κB/iNOS axis. Treatment with Infliximab resulted in downregulation of inflammatory and oxidative–nitrative stress related factors, attenuation of capillary wall cells injury, and relative reduction of capillary hemostasis. These improved the delay in recovery of microcirculation and venous blood flow.
- 24 June 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-16
Open AccessAssessment of cerebrovascular alterations induced by inflammatory response and oxidative–nitrative stress after traumatic intracranial hypertension and a potential mitigation strategy
The rapid perfusion of cerebral arteries leads to a significant increase in intracranial blood volume, exposing patients with traumatic brain injury to the risk of diffuse brain swelling or malignant brain herniation during decompressive craniectomy. The microcirculation and venous system are also involved in this process, but the precise mechanisms remain unclear. A physiological model of extremely high intracranial pressure was created in rats. This development triggered the TNF-α/NF-κB/iNOS axis in microglia, and released many inflammatory factors and reactive oxygen species/reactive nitrogen species, generating an excessive amount of peroxynitrite. Subsequently, the capillary wall cells especially pericytes exhibited severe degeneration and injury, the blood–brain barrier was disrupted, and a large number of blood cells were deposited within the microcirculation, resulting in a significant delay in the recovery of the microcirculation and venous blood flow compared to arterial flow, and this still persisted after decompressive craniectomy. Infliximab is a monoclonal antibody bound to TNF-α that effectively reduces the activity of TNF-α/NF-κB/iNOS axis. Treatment with Infliximab resulted in downregulation of inflammatory and oxidative–nitrative stress related factors, attenuation of capillary wall cells injury, and relative reduction of capillary hemostasis. These improved the delay in recovery of microcirculation and venous blood flow.
- Open Access
- 10 April 2024
- Published by IMR Press in Journal of Integrative Neuroscience
- Vol. 23 (4) , 76
Association between Lipid-Lowering Drugs and Traumatic Subdural Hemorrhage: A Mendelian Randomization Study
Background: There are current clinical observations that atorvastatin may promote subdural hematoma resorption. We aimed to assess the causal effects of lipid-lowering agents 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) inhibitors, Proproteinconvertase subtilisin/kexin type 9 (PCSK9) inhibitors and Niemann-Pick C1-like protein 1 (NPC1L1) inhibitors on traumatic subdural hematomas. Methods: We used genetic instruments to proxy lipid-lowering drug exposure, with genetic instruments being genetic variants within or near low-density lipoprotein (LDL cholesterol)-associated drug target genes. These were analyzed by using a two-sample Mendelian randomization (MR) study. Results: A causal relationship was found between HMGCR inhibitors and traumatic subdural hematoma (Inverse variance weighted (β = –0.7593341 (Odds Ratio (OR) = 0.4679779), p = 0.008366947 < 0.05)). However, no causal relationship was found between PCSK9 inhibitors and NPC1L1 inhibitors and traumatic subdural hematoma (PCSK9 inhibitors: Inverse variance weighted (β = 0.23897796 (OR = 1.2699505), p = 0.1126327), NPC1L1 inhibitors: Inverse variance weighted (β = –0.02118558 (OR = 0.9790373), p = 0.9701686)). Sensitivity analysis of the data revealed good stability of the results. Conclusions: This two-sample MR study suggests a potential causal relationship between HMGCR inhibition (atorvastatin) and traumatic subdural hemorrhage.
- 10 April 2024
- Published by IMR Press in Journal of Integrative Neuroscience
- Vol. 23 (4) , 76
Open AccessAssociation between Lipid-Lowering Drugs and Traumatic Subdural Hemorrhage: A Mendelian Randomization Study
Background: There are current clinical observations that atorvastatin may promote subdural hematoma resorption. We aimed to assess the causal effects of lipid-lowering agents 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) inhibitors, Proproteinconvertase subtilisin/kexin type 9 (PCSK9) inhibitors and Niemann-Pick C1-like protein 1 (NPC1L1) inhibitors on traumatic subdural hematomas. Methods: We used genetic instruments to proxy lipid-lowering drug exposure, with genetic instruments being genetic variants within or near low-density lipoprotein (LDL cholesterol)-associated drug target genes. These were analyzed by using a two-sample Mendelian randomization (MR) study. Results: A causal relationship was found between HMGCR inhibitors and traumatic subdural hematoma (Inverse variance weighted (β = –0.7593341 (Odds Ratio (OR) = 0.4679779), p = 0.008366947 < 0.05)). However, no causal relationship was found between PCSK9 inhibitors and NPC1L1 inhibitors and traumatic subdural hematoma (PCSK9 inhibitors: Inverse variance weighted (β = 0.23897796 (OR = 1.2699505), p = 0.1126327), NPC1L1 inhibitors: Inverse variance weighted (β = –0.02118558 (OR = 0.9790373), p = 0.9701686)). Sensitivity analysis of the data revealed good stability of the results. Conclusions: This two-sample MR study suggests a potential causal relationship between HMGCR inhibition (atorvastatin) and traumatic subdural hemorrhage.
- Open Access
- 1 April 2024
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 17, 2147-2158
TAK-3 Inhibits Lipopolysaccharide-Induced Neuroinflammation in Traumatic Brain Injury Rats Through the TLR-4/NF-κB Pathway
Purpose: The activation of the inflammatory response is regarded as a pivotal factor in the pathogenesis of TBI. Central nervous system infection often leads to the exacerbation of neuroinflammation following TBI, primarily caused by Gram-negative bacteria. This study aims to elucidate the effects of the novel anti-inflammatory drug TAK-3 on LPS-induced neuroinflammation in TBI rats. Methods: In conjunction with the rat controlled cortical impact model, we administered local injections of Lipopolysaccharide to the impact site. Subsequently, interventions were implemented through intraperitoneal injections of TAK-3 and NF-κB activitor2 to modulate the TLR4/NF-κB axis The impact of LPS on neurological function was assessed using mNSS, open field test, and brain water content measurement. Inflammatory markers, including TNF-α, IL-1β, IL-6 and IL-10 were assessed to evaluate the condition of neuritis by Elisa. The activation of the TLR-4/NF-κB signaling pathway was detected by immunofluorescence staining and Western blot to assess the anti-inflammatory effects of TAK-3. Results: The administration of LPS exacerbated neurological damage in rats with TBI, as evidenced by a reduction in motor activity and an increase in anxiety-like behavior. Furthermore, LPS induced disruption of the blood-brain barrier integrity and facilitated the development of brain edema. The activation of microglia and astrocytes by LPS at the cellular and molecular levels has been demonstrated to induce a significant upregulation of neuroinflammatory factors. The injection of TAK-3 attenuated the neuroinflammatory response induced by LPS. Conclusion: The present study highlights the exacerbating effects of LPS on neuroinflammation in TBI through activation of the TLR-4/NF-κB signaling pathway. TAK-3 can modulate the activity of this signaling axis, thereby attenuating neuroinflammation and ultimately reducing brain tissue damage.
- 1 April 2024
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 17, 2147-2158
Open AccessTAK-3 Inhibits Lipopolysaccharide-Induced Neuroinflammation in Traumatic Brain Injury Rats Through the TLR-4/NF-κB Pathway
Purpose: The activation of the inflammatory response is regarded as a pivotal factor in the pathogenesis of TBI. Central nervous system infection often leads to the exacerbation of neuroinflammation following TBI, primarily caused by Gram-negative bacteria. This study aims to elucidate the effects of the novel anti-inflammatory drug TAK-3 on LPS-induced neuroinflammation in TBI rats. Methods: In conjunction with the rat controlled cortical impact model, we administered local injections of Lipopolysaccharide to the impact site. Subsequently, interventions were implemented through intraperitoneal injections of TAK-3 and NF-κB activitor2 to modulate the TLR4/NF-κB axis The impact of LPS on neurological function was assessed using mNSS, open field test, and brain water content measurement. Inflammatory markers, including TNF-α, IL-1β, IL-6 and IL-10 were assessed to evaluate the condition of neuritis by Elisa. The activation of the TLR-4/NF-κB signaling pathway was detected by immunofluorescence staining and Western blot to assess the anti-inflammatory effects of TAK-3. Results: The administration of LPS exacerbated neurological damage in rats with TBI, as evidenced by a reduction in motor activity and an increase in anxiety-like behavior. Furthermore, LPS induced disruption of the blood-brain barrier integrity and facilitated the development of brain edema. The activation of microglia and astrocytes by LPS at the cellular and molecular levels has been demonstrated to induce a significant upregulation of neuroinflammatory factors. The injection of TAK-3 attenuated the neuroinflammatory response induced by LPS. Conclusion: The present study highlights the exacerbating effects of LPS on neuroinflammation in TBI through activation of the TLR-4/NF-κB signaling pathway. TAK-3 can modulate the activity of this signaling axis, thereby attenuating neuroinflammation and ultimately reducing brain tissue damage.
- Open Access
- 27 March 2023
- Published by Springer Nature in European Journal of Medical Research
- Vol. 28 (1) , 1-16
Acute subdural haematoma exacerbates cerebral blood flow disorder and promotes the development of intraoperative brain bulge in patients with severe traumatic brain injury
Background: Decompressive craniectomy (DC) is a routine procedure used for the treatment of severe traumatic brain injury (TBI) with concomitant acute subdural haematoma (SDH). However, certain patients are prone to developing malignant brain bulge during DC, which prolongs the operative time and worsens patient outcomes. Previous studies have shown that malignant intraoperative brain bulge (IOBB) may be associated with excessive arterial hyperaemia caused by cerebrovascular system disorders. Through a clinical retrospective analysis and prospective observations, we found that the cerebral blood flow of patients who possessed risk factors manifested high resistance and low flow velocity, which severely affected brain tissue perfusion and resulted in the occurrence of malignant IOBB. In the current literature, rat models of severe brain injury-associated brain bulge have rarely been reported. Methods: To gain an in-depth understanding of cerebrovascular changes and the cascade of responses related to brain bulge, we introduced acute SDH into the Marmarou model for the preparation of a rat model of high intracranial pressure (ICP) to simulate the pathological conditions experienced by patients with severe brain injury. Results: With the introduction of a 400-µL haematoma, significant dynamic changes occurred in ICP, mean arterial pressure, and relative blood perfusion rate of the cerebral cortical vessels. ICP increased to 56.9 ± 2.3 mmHg, mean arterial pressure showed reactive decrease, and the blood flow of cerebral cortical arteries and veins on the non-SDH-affected side decreased to < 10%. These changes could not fully recover even after DC. This resulted in generalised damage to the neurovascular unit and a lag effect to the venous blood reflux, which triggered malignant IOBB formation during DC. Conclusion: An excessive increase in ICP causes cerebrovascular dysfunction and brings about a cascade of damage to brain tissue, which forms the basis for the development of diffuse brain swelling. The subsequent heterogeneous responses of the cerebral arteries and veins during craniotomy may be the main cause of primary IOBB. Clinicians should pay particular attention to the redistribution of CBF to various vessels when performing DC in patients with severe TBI.
- 27 March 2023
- Published by Springer Nature in European Journal of Medical Research
- Vol. 28 (1) , 1-16
Open AccessAcute subdural haematoma exacerbates cerebral blood flow disorder and promotes the development of intraoperative brain bulge in patients with severe traumatic brain injury
Background: Decompressive craniectomy (DC) is a routine procedure used for the treatment of severe traumatic brain injury (TBI) with concomitant acute subdural haematoma (SDH). However, certain patients are prone to developing malignant brain bulge during DC, which prolongs the operative time and worsens patient outcomes. Previous studies have shown that malignant intraoperative brain bulge (IOBB) may be associated with excessive arterial hyperaemia caused by cerebrovascular system disorders. Through a clinical retrospective analysis and prospective observations, we found that the cerebral blood flow of patients who possessed risk factors manifested high resistance and low flow velocity, which severely affected brain tissue perfusion and resulted in the occurrence of malignant IOBB. In the current literature, rat models of severe brain injury-associated brain bulge have rarely been reported. Methods: To gain an in-depth understanding of cerebrovascular changes and the cascade of responses related to brain bulge, we introduced acute SDH into the Marmarou model for the preparation of a rat model of high intracranial pressure (ICP) to simulate the pathological conditions experienced by patients with severe brain injury. Results: With the introduction of a 400-µL haematoma, significant dynamic changes occurred in ICP, mean arterial pressure, and relative blood perfusion rate of the cerebral cortical vessels. ICP increased to 56.9 ± 2.3 mmHg, mean arterial pressure showed reactive decrease, and the blood flow of cerebral cortical arteries and veins on the non-SDH-affected side decreased to < 10%. These changes could not fully recover even after DC. This resulted in generalised damage to the neurovascular unit and a lag effect to the venous blood reflux, which triggered malignant IOBB formation during DC. Conclusion: An excessive increase in ICP causes cerebrovascular dysfunction and brings about a cascade of damage to brain tissue, which forms the basis for the development of diffuse brain swelling. The subsequent heterogeneous responses of the cerebral arteries and veins during craniotomy may be the main cause of primary IOBB. Clinicians should pay particular attention to the redistribution of CBF to various vessels when performing DC in patients with severe TBI.
- Open Access
- 24 October 2022
- Published by Springer Nature in Research Square
TRPV1 participates in neuropathic pain after spinal cord injury by mediating the proliferation and activation of CX3CL1-positive glial cells in the spinal dorsal horn
Background Patients with spinal cord injury (SCI) often present with different degrees of neuropathic pain (NP). Glia-mediated inflammatory response plays a key role. The transient receptor potential vanilloid subtype 1 (TRPV1), as an ion channel receptor closely related to pain, plays an important role in NP, although its mechanism remains unclear. We explored the role of TRPV1 in NP after SCI and its effect on the proliferation and activation of C-X3-C motif chemokine ligand 1 (CX3CL1)-positive glial cells. Methods The SCI rat model was established using the modified Allen’s spinal cord injury model. After SCI, rats in each group were administered the TRPV1 antagonist SB705498 (10 mg/kg) or 2 mL of vehicle intragastrically for 7 consecutive days. The hindlimb motor function of rats after injury was assessed by the Basso, Beattie, and Bresnahan rating scale; Von Frey fibres and plantar thermal stimulation were used to evaluate the changes in rats’ mechanical paw withdrawal threshold (PWT) and thermal paw withdrawal latency (PWL), respectively; haematoxylin and eosin staining, double immunofluorescent staining, and Western blotting were used to investigate the role of TRPV1 in NP after SCI and its effect on the proliferation and activation of CX3CL1-positive glial cells. Results The chemokine CX3CL1 was mainly expressed in the dorsal horn neurons of the spinal cord and also to a certain extent in microglia, astrocytes, and oligodendrocytes after SCI. The expression of TRPV1 and CX3CL1 in the dorsal horn of the spinal cord in rats was significantly upregulated, and the PWT and PWL of rats were significantly decreased after SCI. The TRPV1 antagonist not only inhibited the activation of TRPV1, but also significantly inhibited the apoptosis of neurons and oligodendrocytes and proliferation and activation of inflammation-related CX3CL1-positive glial cells induced by SCI. Conclusion These results suggest that TRPV1 is involved in the occurrence and development of NP after SCI in rats by mediating the proliferation and activation of CX3CL1-positive glial cells in the dorsal horn of the spinal cord; inhibition of TRPV1 activity attenuates the proliferation and activation of CX3CL1-positive glial cells, thereby reducing symptoms of central sensitisation.
- 24 October 2022
- Published by Springer Nature in Research Square
Open AccessTRPV1 participates in neuropathic pain after spinal cord injury by mediating the proliferation and activation of CX3CL1-positive glial cells in the spinal dorsal horn
Background Patients with spinal cord injury (SCI) often present with different degrees of neuropathic pain (NP). Glia-mediated inflammatory response plays a key role. The transient receptor potential vanilloid subtype 1 (TRPV1), as an ion channel receptor closely related to pain, plays an important role in NP, although its mechanism remains unclear. We explored the role of TRPV1 in NP after SCI and its effect on the proliferation and activation of C-X3-C motif chemokine ligand 1 (CX3CL1)-positive glial cells. Methods The SCI rat model was established using the modified Allen’s spinal cord injury model. After SCI, rats in each group were administered the TRPV1 antagonist SB705498 (10 mg/kg) or 2 mL of vehicle intragastrically for 7 consecutive days. The hindlimb motor function of rats after injury was assessed by the Basso, Beattie, and Bresnahan rating scale; Von Frey fibres and plantar thermal stimulation were used to evaluate the changes in rats’ mechanical paw withdrawal threshold (PWT) and thermal paw withdrawal latency (PWL), respectively; haematoxylin and eosin staining, double immunofluorescent staining, and Western blotting were used to investigate the role of TRPV1 in NP after SCI and its effect on the proliferation and activation of CX3CL1-positive glial cells. Results The chemokine CX3CL1 was mainly expressed in the dorsal horn neurons of the spinal cord and also to a certain extent in microglia, astrocytes, and oligodendrocytes after SCI. The expression of TRPV1 and CX3CL1 in the dorsal horn of the spinal cord in rats was significantly upregulated, and the PWT and PWL of rats were significantly decreased after SCI. The TRPV1 antagonist not only inhibited the activation of TRPV1, but also significantly inhibited the apoptosis of neurons and oligodendrocytes and proliferation and activation of inflammation-related CX3CL1-positive glial cells induced by SCI. Conclusion These results suggest that TRPV1 is involved in the occurrence and development of NP after SCI in rats by mediating the proliferation and activation of CX3CL1-positive glial cells in the dorsal horn of the spinal cord; inhibition of TRPV1 activity attenuates the proliferation and activation of CX3CL1-positive glial cells, thereby reducing symptoms of central sensitisation.